Regenerex Pharma (RGPX) Other Working Capital Changes (2011 - 2025)

Regenerex Pharma (RGPX) has 10 years of Other Working Capital Changes data on file, last reported at -$16520.0 in Q3 2025.

• Other Working Capital Changes for Q3 2025 came in at -$16520.0, down 2124.51% year-over-year; the trailing twelve-month figure through Sep 2025 was -$35229.0 (down 400.87% YoY), and the FY2025 annual result was $2190.0, up 186.22% from the prior year.
• Other Working Capital Changes climbed to -$16520.0 in Q3 2025 per RGPX's latest filing, from -$19900.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $11827.0 in Q4 2023 and troughed at -$23300.0 in Q2 2023.
• A 5-year average of -$2222.3 and a median of $370.5 in 2021 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes surged 233.53% in 2022, then tumbled 10974.32% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at $2836.0 in 2021, then fell by 2.82% to $2756.0 in 2022, then soared by 329.14% to $11827.0 in 2023, then tumbled by 92.47% to $891.0 in 2024, then plunged by 1954.1% to -$16520.0 in 2025.
• Business Quant data shows RGPX's Other Working Capital Changes at -$16520.0 in Q3 2025, -$19900.0 in Q2 2025, and $300.0 in Q1 2025.